Concepedia

Publication | Open Access

Longitudinal Assessment of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019

DOIFull Paper Access

29

Citations

26

References

2021

Year

Ji Yun Noh, Jeong-Eun Kwak, Jeong-Sun Yang, Soon Young Hwang, Jin Gu Yoon, Hye Seong, Hakjun Hyun, Chae Seung Lim, Soo‐Young Yoon, Jungsang Ryou,
The Journal of Infectious Diseases

Abstract

In conclusion, most (>85%) patients carry NAb until 6 months after diagnosis of SARS-CoV-2 infection, providing insights for establishing vaccination strategies against COVID-19.

References

YearCitations

Page 1